Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
Sales | 23 | 65 | 147 | 289 | 253 |
Cost of Goods | 3 | 9 | 44 | 47 | 51 |
Gross Profit | 20 | 56 | 103 | 243 | 202 |
Operating Expenses | 1,119 | 1,839 | 2,979 | 1,102 | 1,132 |
Operating Income | -1,096 | -1,774 | -2,833 | -812 | -879 |
Interest Expense | 235 | 212 | 483 | 1,004 | 650 |
Other Income | 0 | 12,024 | 0 | 0 | 0 |
Pre-tax Income | -1,331 | 10,038 | -3,316 | -1,816 | -1,529 |
Income Tax | N/A | N/A | 1 | N/A | N/A |
Net Income Continuous | -1,331 | 10,038 | -3,316 | -1,816 | -1,529 |
Net Income | $-1,331 | $10,038 | $-3,316 | $-1,816 | $-1,529 |
EPS Basic Total Ops | -479.04 | 1,916.17 | -479.04 | -479.04 | -479.04 |
EPS Basic Continuous Ops | -243.90 | 1,909.60 | -713.43 | -429.38 | -379.93 |
EPS Diluted Total Ops | -479.04 | 1,916.17 | -479.04 | -479.04 | -479.04 |
EPS Diluted Continuous Ops | -243.90 | 1,720.25 | -713.43 | -429.38 | -379.93 |
EBITDA(a) | $-776 | $-1,466 | $-2,222 | $339 | $-90 |